 | • レポートコード：QYR9N7970 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、リウマチ性心疾患のグローバル市場について調査・分析したレポートで、種類別（弁、心筋炎、心膜炎）、用途別（病院、診断センター、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・リウマチ性心疾患の世界市場規模 ・主要企業別市場シェア ・リウマチ性心疾患の世界市場規模：種類別（弁、心筋炎、心膜炎） ・リウマチ性心疾患の世界市場規模：用途別（病院、診断センター、研究センター） ・リウマチ性心疾患のアメリカ市場規模（種類別、用途別） ・リウマチ性心疾患のヨーロッパ市場規模（種類別、用途別） ・リウマチ性心疾患の中国市場規模（種類別、用途別） ・リウマチ性心疾患の日本市場規模（種類別、用途別） ・リウマチ性心疾患の東南アジア市場規模（種類別、用途別） ・リウマチ性心疾患のインド市場規模（種類別、用途別） ・リウマチ性心疾患の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・リウマチ性心疾患の世界市場予測（2019年-2025年） ・リウマチ性心疾患の地域別市場予測（2019年-2025年） ... |
Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expenditure by government to tackle rising prevalence of cardiovascular disease is another motivating factor for the market.
In 2018, the global Rheumatic Heart Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Rheumatic Heart Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rheumatic Heart Disease development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
GE Healthcare
InterValve
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
Siemens Healthineers
Toray
Market segment by Type, the product can be split into
Valve
Myocarditis
Pericarditis
Market segment by Application, split into
Hospital
Diagnostic Centre
Research Centre
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Rheumatic Heart Disease status, future forecast, growth opportunity, key market and key players.
To present the Rheumatic Heart Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Rheumatic Heart Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rheumatic Heart Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Valve
1.4.3 Myocarditis
1.4.4 Pericarditis
1.5 Market by Application
1.5.1 Global Rheumatic Heart Disease Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Diagnostic Centre
1.5.4 Research Centre
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Rheumatic Heart Disease Market Size
2.2 Rheumatic Heart Disease Growth Trends by Regions
2.2.1 Rheumatic Heart Disease Market Size by Regions (2014-2025)
2.2.2 Rheumatic Heart Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Rheumatic Heart Disease Market Size by Manufacturers
3.1.1 Global Rheumatic Heart Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Rheumatic Heart Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rheumatic Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatic Heart Disease Key Players Head office and Area Served
3.3 Key Players Rheumatic Heart Disease Product/Solution/Service
3.4 Date of Enter into Rheumatic Heart Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Rheumatic Heart Disease Market Size by Type (2014-2019)
4.2 Global Rheumatic Heart Disease Market Size by Application (2014-2019)
5 United States
5.1 United States Rheumatic Heart Disease Market Size (2014-2019)
5.2 Rheumatic Heart Disease Key Players in United States
5.3 United States Rheumatic Heart Disease Market Size by Type
5.4 United States Rheumatic Heart Disease Market Size by Application
6 Europe
6.1 Europe Rheumatic Heart Disease Market Size (2014-2019)
6.2 Rheumatic Heart Disease Key Players in Europe
6.3 Europe Rheumatic Heart Disease Market Size by Type
6.4 Europe Rheumatic Heart Disease Market Size by Application
7 China
7.1 China Rheumatic Heart Disease Market Size (2014-2019)
7.2 Rheumatic Heart Disease Key Players in China
7.3 China Rheumatic Heart Disease Market Size by Type
7.4 China Rheumatic Heart Disease Market Size by Application
8 Japan
8.1 Japan Rheumatic Heart Disease Market Size (2014-2019)
8.2 Rheumatic Heart Disease Key Players in Japan
8.3 Japan Rheumatic Heart Disease Market Size by Type
8.4 Japan Rheumatic Heart Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Rheumatic Heart Disease Market Size (2014-2019)
9.2 Rheumatic Heart Disease Key Players in Southeast Asia
9.3 Southeast Asia Rheumatic Heart Disease Market Size by Type
9.4 Southeast Asia Rheumatic Heart Disease Market Size by Application
10 India
10.1 India Rheumatic Heart Disease Market Size (2014-2019)
10.2 Rheumatic Heart Disease Key Players in India
10.3 India Rheumatic Heart Disease Market Size by Type
10.4 India Rheumatic Heart Disease Market Size by Application
11 Central & South America
11.1 Central & South America Rheumatic Heart Disease Market Size (2014-2019)
11.2 Rheumatic Heart Disease Key Players in Central & South America
11.3 Central & South America Rheumatic Heart Disease Market Size by Type
11.4 Central & South America Rheumatic Heart Disease Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rheumatic Heart Disease Introduction
12.1.4 Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rheumatic Heart Disease Introduction
12.2.4 Bayer Revenue in Rheumatic Heart Disease Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 BIOTRONIK
12.3.1 BIOTRONIK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rheumatic Heart Disease Introduction
12.3.4 BIOTRONIK Revenue in Rheumatic Heart Disease Business (2014-2019)
12.3.5 BIOTRONIK Recent Development
12.4 Boston Scientific
12.4.1 Boston Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rheumatic Heart Disease Introduction
12.4.4 Boston Scientific Revenue in Rheumatic Heart Disease Business (2014-2019)
12.4.5 Boston Scientific Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rheumatic Heart Disease Introduction
12.5.4 Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 C. R. Bard
12.6.1 C. R. Bard Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rheumatic Heart Disease Introduction
12.6.4 C. R. Bard Revenue in Rheumatic Heart Disease Business (2014-2019)
12.6.5 C. R. Bard Recent Development
12.7 Cardinal Health
12.7.1 Cardinal Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rheumatic Heart Disease Introduction
12.7.4 Cardinal Health Revenue in Rheumatic Heart Disease Business (2014-2019)
12.7.5 Cardinal Health Recent Development
12.8 Cook Medical
12.8.1 Cook Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rheumatic Heart Disease Introduction
12.8.4 Cook Medical Revenue in Rheumatic Heart Disease Business (2014-2019)
12.8.5 Cook Medical Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rheumatic Heart Disease Introduction
12.9.4 Roche Revenue in Rheumatic Heart Disease Business (2014-2019)
12.9.5 Roche Recent Development
12.10 GE Healthcare
12.10.1 GE Healthcare Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rheumatic Heart Disease Introduction
12.10.4 GE Healthcare Revenue in Rheumatic Heart Disease Business (2014-2019)
12.10.5 GE Healthcare Recent Development
12.11 InterValve
12.12 Novartis
12.13 On-X Life Technologies
12.14 Osypka Medical
12.15 Otsuka
12.16 PerkinElmer
12.17 Pfizer
12.18 Reckitt Benckiser
12.19 Siemens Healthineers
12.20 Toray
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Rheumatic Heart Disease Key Market Segments
Table Key Players Rheumatic Heart Disease Covered
Table Global Rheumatic Heart Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rheumatic Heart Disease Market Size Market Share by Type 2014-2025
Figure Valve Figures
Table Key Players of Valve
Figure Myocarditis Figures
Table Key Players of Myocarditis
Figure Pericarditis Figures
Table Key Players of Pericarditis
Table Global Rheumatic Heart Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Diagnostic Centre Case Studies
Figure Research Centre Case Studies
Figure Rheumatic Heart Disease Report Years Considered
Table Global Rheumatic Heart Disease Market Size 2014-2025 (Million US$)
Figure Global Rheumatic Heart Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rheumatic Heart Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Rheumatic Heart Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Rheumatic Heart Disease Market Share by Regions 2014-2019
Figure Global Rheumatic Heart Disease Market Share by Regions 2014-2019
Figure Global Rheumatic Heart Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Rheumatic Heart Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rheumatic Heart Disease Market Share by Manufacturers (2014-2019)
Figure Global Rheumatic Heart Disease Market Share by Manufacturers in 2018
Table Global Rheumatic Heart Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rheumatic Heart Disease Product/Solution/Service
Table Date of Enter into Rheumatic Heart Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Global Rheumatic Heart Disease Market Size Share by Type (2014-2019)
Figure Global Rheumatic Heart Disease Market Size Market Share by Type (2014-2019)
Table Global Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Global Rheumatic Heart Disease Market Size Share by Application (2014-2019)
Figure Global Rheumatic Heart Disease Market Size Market Share by Application (2014-2019)
Figure Global Rheumatic Heart Disease Revenue Market Share by Application in 2018
Figure United States Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table United States Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table United States Rheumatic Heart Disease Market Share by Type (2014-2019)
Table United States Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table United States Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure Europe Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table Europe Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Rheumatic Heart Disease Market Share by Type (2014-2019)
Table Europe Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure China Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table China Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table China Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table China Rheumatic Heart Disease Market Size by Type (2014-20189) (Million US$)
Table China Rheumatic Heart Disease Market Share by Type (2014-2019)
Table China Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table China Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure Japan Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table Japan Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Rheumatic Heart Disease Market Share by Type (2014-2019)
Table Japan Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure Southeast Asia Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table Southeast Asia Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rheumatic Heart Disease Market Share by Type (2014-2019)
Table Southeast Asia Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure India Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table India Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table India Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table India Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table India Rheumatic Heart Disease Market Share by Type (2014-2019)
Table India Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table India Rheumatic Heart Disease Market Share by Application (2014-2019)
Figure Central & South America Rheumatic Heart Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rheumatic Heart Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rheumatic Heart Disease Market Share (2018-2019)
Table Central & South America Rheumatic Heart Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rheumatic Heart Disease Market Share by Type (2014-2019)
Table Central & South America Rheumatic Heart Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rheumatic Heart Disease Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Bayer Company Details
Table Bayer Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Bayer Recent Development
Table BIOTRONIK Company Details
Table BIOTRONIK Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure BIOTRONIK Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table BIOTRONIK Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Boston Scientific Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table C. R. Bard Company Details
Table C. R. Bard Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure C. R. Bard Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table C. R. Bard Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Cardinal Health Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Cardinal Health Recent Development
Table Cook Medical Company Details
Table Cook Medical Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Cook Medical Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Cook Medical Recent Development
Table Roche Company Details
Table Roche Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table Roche Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Rheumatic Heart Disease Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Rheumatic Heart Disease Business (2014-2019)
Table GE Healthcare Recent Development
Table InterValve Company Details
Table Novartis Company Details
Table On-X Life Technologies Company Details
Table Osypka Medical Company Details
Table Otsuka Company Details
Table PerkinElmer Company Details
Table Pfizer Company Details
Table Reckitt Benckiser Company Details
Table Siemens Healthineers Company Details
Table Toray Company Details
Table Global Rheumatic Heart Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Rheumatic Heart Disease Market Size Share by Regions (2019-2025)
Figure Global Rheumatic Heart Disease Market Size Share by Regions in 2025
Figure United States Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rheumatic Heart Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Rheumatic Heart Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Rheumatic Heart Disease Market Size by Product (2019-2025)
Figure Global Rheumatic Heart Disease Market Size by Product in 2025
Table Global Rheumatic Heart Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Rheumatic Heart Disease Market Size by Application (2019-2025)
Figure Global Rheumatic Heart Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の炎症性心疾患市場：市場規模・現状・予測 Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment.Changing lifestyle resulting in higher prevalence of viral and fu…- 世界のリウマチ熱治療市場：市場規模・現状・予測 Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition.G…
- 世界の先天性心疾患市場：市場規模・現状・予測 A congenital heart disease is a problem in the structure of the heart that is present at birth.The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number o…
- 世界の遺伝病診断市場：市場規模・現状・予測 Test the genetic disease. For example, color blindness, Down'ssyndrome, cystic fibrosis,etcRising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additio…
- 世界の構造心臓イメージング（SHI）市場：市場規模・現状・予測 In 2018, the global Structural Heart Imaging (SHI) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Structural Heart Imaging (SHI) status, future forecast, growth opportunity, key market and key…